IsoPlexis, a company uncovering a ‘new layer’ of cell data, aims for $125M in market debut
www.techcrunch.com Shares of IsoPlexis, a company creating tools to zoom in on the flurry of protein activity surrounding a single cell, began trading on Friday. The company aims to raise about $125 million with the IPO, which will be used to build the commercial team and advance the company’s plans to play a bigger part…